human
siglec
famili
sialic
acidbind
protein
express
subset
immun
cell
regul
immun
respons
express
select
human
allerg
inflammatori
cellsprimarili
eosinophil
mast
cellswher
engag
caus
eosinophil
apoptosi
inhibit
mast
cell
mediat
releas
evid
support
model
human
eosinophil
mast
cell
bind
sialoglycan
ligand
inflammatori
target
tissu
resolv
allerg
inflamm
limit
tissu
damag
identifi
sialoglycan
human
airway
protein
extract
postmortem
human
trachea
resolv
sizeexclus
chromatographi
composit
agaroseacrylamid
gel
electrophoresi
blot
probe
blot
overlay
three
size
class
ligand
identifi
kda
kda
mda
purifi
affin
chromatographi
use
recombin
pentamer
form
proteom
mass
spectrometri
identifi
size
class
proteoglycan
aggrecan
find
valid
immunoblot
glycan
array
studi
demonstr
bind
synthet
glycan
termin
gal
determin
quantit
minor
terminu
keratan
sulfat
ks
chain
aggrecan
treat
human
tracheal
extract
sialidas
keratanas
elimin
bind
indic
sialyl
ks
chain
determin
treat
human
tracheal
histolog
section
keratanas
also
complet
elimin
bind
final
ligand
purifi
human
trachea
extract
induc
increas
apoptosi
freshli
isol
human
eosinophil
vitro
conclud
sialyl
ks
proteoglycan
endogen
human
airway
ligand
bind
may
regul
allerg
inflamm
inflamm
care
tune
maxim
clearanc
pathogen
limit
host
tissu
damag
fullerton
gilroy
barnig
et
al
proinflammatori
signal
essenti
host
protect
time
resolut
requir
prevent
excess
chronic
inflammatori
tissu
damag
among
regul
inflamm
member
siglec
famili
sialic
acidbind
immunoglobulinlik
lectin
express
overlap
set
immun
cell
mani
carri
intracellular
immunoreceptor
tyrosinebas
inhibitori
motif
itim
domain
aid
resolut
immun
respons
macauley
et
al
focu
current
studi
uniqu
select
express
human
eosinophil
mast
cell
basophil
implic
allerg
inflamm
bochner
schleimer
et
al
transmembran
protein
outermost
ntermin
iglik
domain
mediat
sialic
acid
glycan
bind
intracellular
domain
carri
itim
itimlik
domain
experiment
antibodyinduc
crosslink
surfac
eosinophil
result
transmembran
signal
induc
eosinophil
apoptosi
wherea
crosslink
mast
cell
inhibit
releas
immun
mediat
yokoi
et
al
notabl
effect
crosslink
greater
inflammatori
cell
activ
rather
quiescent
state
nutkubilir
et
al
suggest
downregul
inflammatori
cell
natur
step
resolv
ongo
allerg
inflamm
limit
tissu
damag
hypothesi
support
discoveri
human
gene
polymorph
associ
suscept
asthma
gao
et
al
current
hypothesi
consist
data
allerg
inflammatori
cell
engag
polyval
complementari
bind
sialoglycan
target
tissu
integr
step
resolv
appropri
limit
allerg
inflamm
ident
regul
sialoglycan
inflammatori
target
tissu
focu
ongo
investig
although
endogen
sialoglycan
ligand
identifi
screen
synthet
sialoglycan
reveal
among
specif
lectin
test
favor
sialic
acid
link
galactos
also
carri
sulfat
ester
group
eg
bochner
et
al
yu
et
al
find
confirm
structur
elucid
bound
lewi
x
glcnacr
sulfat
galactos
engag
arginin
bind
pocket
propster
et
al
result
implic
sialyl
glycan
target
tissu
function
ligand
prior
studi
jia
et
al
yu
et
al
use
express
solubl
human
fc
chimera
probe
endogen
ligand
human
upper
lower
airway
clinic
relev
target
allerg
inflamm
use
lectin
overlay
histochemistri
postmortem
lower
human
airway
found
ligand
strongli
express
tracheal
bronchial
submucos
gland
cartilag
mous
airway
fail
bind
consist
absenc
ligand
mous
airway
furthermor
found
ligand
extract
human
airway
tissu
use
guanidinium
hydrochlorid
guhcl
nonion
deterg
resolv
composit
agaroseacrylamid
electrophoresi
primarili
largemolecular
weight
speci
olink
glycan
comigr
singl
major
airway
mucin
yu
et
al
current
studi
purifi
ligand
human
tracheal
extract
sequenti
sizeexclus
chromatographi
affin
chromatographi
identifi
proteom
mass
spectrometri
valid
candid
molecul
reveal
sialyl
ks
proteoglycan
primari
carrier
ligand
human
airway
provid
suffici
multival
avid
highstring
affin
purif
siglec
ligand
extract
natur
sourc
spontan
pentamer
solubl
chimera
extracellular
domain
design
creat
base
previous
publish
strategi
voulgaraki
et
al
three
ntermin
extracellular
iglik
domain
human
fuse
short
spacer
two
ig
domain
spontan
pentamer
domain
cartilag
oligomer
matrix
protein
ctermin
tag
figur
b
denatur
polyacrylamid
gel
electrophoresi
express
solubl
protein
product
molecular
weight
kda
expect
figur
insert
upon
nondenatur
sizeexclus
chromatographi
figur
multimer
speci
detect
includ
expect
kda
speci
higher
order
aggreg
may
due
residu
nickel
crosslink
cluster
tag
valenti
et
al
direct
comparison
bind
immobil
synthet
target
neoglycolipid
ethylamin
coval
link
n
succinimidyloxyglutaryl
yu
et
al
reveal
halflif
dimer
fc
chimera
minut
wherea
pentaval
bind
halflif
nearli
h
data
shown
specialti
sialoglycan
microarray
use
test
specif
bind
figur
array
contain
neutral
glycan
sialoglycan
sialoglycan
supplementari
data
tabl
two
structur
bound
contain
sialyl
substructur
previous
shown
bind
bochner
et
al
campanerorhod
et
al
kiwamoto
et
al
schnaar
yu
et
al
togeth
data
valid
comp
construct
highavid
specif
chimera
suitabl
affin
purif
natur
ligand
purif
three
size
class
ligand
extract
human
trachea
prior
studi
indic
ligand
preferenti
extract
postmortem
human
airway
use
guhcl
yu
et
al
extract
subject
denatur
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdspage
bind
speci
larg
hardli
enter
gel
electrophoresi
composit
agaroseacrylamid
gel
design
separ
mucin
holden
et
al
reveal
heterogen
mixtur
protein
highmolecular
weight
rang
kda
mda
base
find
ligand
extract
human
trachea
resolv
sizeexclus
chromatographi
use
sephacryl
larg
size
rang
molecul
result
figur
reveal
signific
resolut
compon
elut
differ
major
protein
peak
near
exclud
includ
volum
upon
composit
gel
electrophoresi
sizeexclus
chromatographi
fraction
resolv
three
major
size
class
base
rel
electrophoret
mobil
design
base
appar
molecular
weight
mda
kda
kda
fraction
highli
enrich
tabl
probe
bind
detect
antibodi
mean
standard
error
bind
six
spot
glycan
present
glycan
support
bind
shown
use
symbol
nomenclatur
varki
et
al
obtain
fraction
incomplet
resolv
two
size
class
similar
extract
sever
differ
human
tissu
donor
subject
sizeexclus
chromatographi
electrophoresi
three
size
class
found
variabl
ratio
among
data
shown
purif
pool
size
class
human
tracheal
ligand
perform
affin
chromatographi
use
immobil
nickel
sepharos
column
figur
size
class
aliquot
combin
fraction
sizeexclus
chromatographi
preclear
nickel
sepharos
column
pass
column
everi
case
fraction
materi
retain
thorough
wash
major
bound
ligand
concentr
elut
fraction
elut
accomplish
releas
use
imidazol
compet
nickel
bind
releas
ligand
data
shown
subsequ
studi
reveal
ligand
effici
elut
column
increas
salt
concentr
leav
bound
nickel
column
improv
downstream
analys
purifi
ligand
avoid
coelut
also
allow
repeat
sequenti
affin
column
load
unbound
materi
least
three
time
sizesepar
ligand
affin
captur
elut
affinitypurifi
protein
size
class
subject
proteom
mass
spectrometri
protein
highest
confid
everi
size
class
exclud
contamin
keratin
aggrecan
figur
eighteen
separ
aggrecan
peptid
identifi
among
three
size
class
tabl
distribut
three
distinct
region
protein
aggrecan
larg
amino
acid
protein
three
long
proteoglycan
domainson
keratan
sulfat
ks
rich
two
chondroitin
sulfat
cs
rich
domainsand
three
globular
domain
figur
identifi
peptid
globular
domain
consist
proteolyt
proteom
identif
method
use
confirm
proteom
identif
replic
composit
gel
blot
three
size
class
probe
reveal
antiaggrecan
antibodi
figur
antiaggrecan
antibodi
blot
found
rel
electrophoret
migrat
posit
affinitypurifi
ligand
size
class
use
antibodi
bind
first
two
globular
domain
aggrecan
figur
purifi
also
bound
antiaggrecan
antibodi
wherea
size
class
wherea
proteom
data
lack
peptid
region
perhap
indic
truncat
highconfid
peptid
region
found
k
tabl
indic
loss
antibodyreact
protein
exclus
due
lack
cterminu
nine
highconfid
peptid
identifi
proteom
also
found
eight
nine
highconfid
peptid
aggrecan
typic
carri
signific
amount
two
major
type
proteoglycan
chain
ks
cs
figur
wherea
cs
chain
gener
sialyl
small
proport
ks
chain
carri
termin
sialic
acid
furthermor
portion
galactos
residu
ks
may
carri
togeth
gener
termin
sialyl
sulfat
disaccharid
gal
common
synthet
glycan
discov
ligand
multipl
glycan
array
studi
bochner
et
al
campanerorhod
et
al
kiwamoto
et
al
yu
et
al
figur
test
whether
affin
bind
immobil
bead
via
glycan
bind
site
differ
glycan
test
abil
elut
one
ligand
bound
bead
figur
incub
buffer
alon
fail
elut
ligand
likewis
incub
nacetyllactosamin
lacnac
fail
elut
ligand
contrast
incub
releas
major
ligand
bead
small
amount
releas
data
suggest
bind
purifi
ligand
affin
bead
via
sialoglycanbind
site
test
hypothesi
sialyl
termini
ks
chain
respons
bind
human
airway
ligand
seri
direct
depolymer
experi
perform
first
size
class
purifi
human
tracheal
ligand
subject
treatment
sialidas
keratanas
ii
size
class
treatment
either
enzym
elimin
greatli
diminish
bind
upon
subsequ
electrophoret
resolut
blot
overlay
figur
treatment
enzym
left
protein
carrier
aggrecan
intact
evidenc
bind
antiaggrecan
antibodi
specif
togeth
data
indic
enzymat
remov
sialyl
ks
chain
respons
bind
ligand
size
class
consist
prior
find
yu
et
al
treatment
pngase
f
remov
nlink
glycan
littl
effect
wherea
mild
base
treatment
result
disappear
bind
consist
conclus
ks
chain
olink
supplementari
data
figur
confirm
role
sialyl
ks
chain
ligand
human
airway
two
differ
class
sourc
keratanas
compar
greatli
diminish
elimin
bind
purifi
ligand
keratanas
ii
figur
lane
endonacetylglucosaminidas
prefer
area
high
sulfat
wherea
keratanas
see
figur
lane
endogalactosidas
requir
area
low
sulfat
keratanas
activ
independ
determin
chemic
product
reduc
end
commerci
ks
immunochem
keratanas
activ
ligand
confirm
gain
bind
monoclon
antibodi
akhtar
et
al
detect
keratanas
igener
ks
stub
termini
keratanas
ii
activ
confirm
loss
bind
monoclon
antibodi
caterson
et
al
detect
figur
fraction
correspond
separ
combin
affin
purif
pool
fraction
molecular
size
load
separ
onto
nickel
sepharos
affin
column
carri
pentamer
load
wash
column
bound
ligand
elut
high
salt
equal
aliquot
wash
eluat
subject
acrylamid
agaros
composit
gel
electrophoresi
blot
pvdf
membran
probe
lane
pool
sephacryl
fraction
affin
column
flowthrough
wash
wash
elut
elut
elut
himarkprestain
molecular
weight
standard
shown
left
std
tabl
exceed
strict
fals
discoveri
rate
ligand
size
class
indic
smaller
size
class
k
map
aggrecan
uniprot
refer
sequenc
amino
acid
wherea
largest
size
class
map
ctermin
altern
splice
aggrecan
sequenc
amino
acid
b
schemat
map
aggrecan
igd
interglobular
domain
chondroitin
sulfat
cs
rich
domain
modifi
caterson
melros
permiss
c
comigr
purifi
human
ligand
aggrecan
immunoreact
three
purifi
size
class
ligand
human
trachea
resolv
electrophoresi
replic
acrylamid
agaros
composit
gel
blot
pvdf
membran
probe
antiaggrecan
antibodi
antiaggrecan
antibodi
migrat
posit
himarkprestain
standard
indic
left
lane
gener
schemat
structur
ks
cs
chain
depict
use
symbol
nomenclatur
varki
et
al
sialic
acid
sulfat
variabl
shown
parenthes
e
elut
affin
chromatographi
solubl
glycan
pool
sizeexclus
fraction
contain
figur
captur
magnet
bead
bead
thoroughli
wash
prior
elut
lane
follow
mm
imidazol
elut
bound
remain
ligand
attach
lane
eluat
resolv
composit
gel
electrophoresi
blot
probe
elut
test
follow
none
nacetyllactosamin
lacnac
lacnac
glcnac
highli
sulfat
ks
enzym
prepar
test
neg
contamin
sialidas
activ
data
shown
overlay
histochemistri
reveal
bind
cross
section
fix
human
trachea
mous
trachea
jia
et
al
yu
et
al
human
trachea
strong
bind
seen
submucos
gland
underli
cartilag
bind
human
tracheal
cross
section
complet
elimin
sialidas
pretreat
consist
hypothesi
keratanas
sialidas
pretreat
diminish
bind
purifi
ligand
ligand
extract
human
trachea
purifi
sequenti
sizeexclus
affin
chromatographi
subject
keratanas
sialidas
treatment
sampl
resolv
acrylamid
agaros
composit
gel
blot
pvdf
membran
probe
precomplex
antiaggrecan
antibodi
indic
lane
incub
without
enzym
sialidas
muml
min
keratanas
ii
muml
h
himark
molecular
weight
standard
shown
left
std
human
tracheal
ligand
sialyl
ks
chain
similar
reduct
bind
obtain
histolog
section
human
trachea
pretreat
keratanas
figur
keratanas
pretreat
significantli
reduc
subsequ
bind
cartilag
submucos
gland
keratanas
ii
treatment
complet
elimin
bind
conclud
human
airway
ligand
detect
lectin
overlay
sialyl
ks
proteoglycan
human
trachea
aggrecan
bovin
articular
cartilag
aggrecan
express
sialyl
ks
chain
base
requir
sialic
acid
link
galactos
bind
propster
et
al
requir
ks
chain
elong
funderburgh
propos
determin
aggrecan
ks
chain
termin
disulf
trisaccharid
structur
glcnac
minor
wellestablish
structur
ks
terminu
vertebr
includ
ks
abund
sourc
human
bovin
cornea
articular
cartilag
brown
et
al
brown
et
al
lauder
et
al
lauder
et
al
funderburgh
test
distribut
determin
sourc
aggrecan
purifi
human
ligand
compar
commerci
obtain
bovin
articular
cartilag
compar
amount
antiaggrecan
immunoreact
human
robustli
bound
wherea
bind
bovin
aggrecan
essenti
absent
figur
lane
test
potenti
cs
chain
aggrecan
support
block
bind
bovin
aggrecan
treat
chondroitinas
abc
chabc
prior
electrophoret
resolut
blot
chabc
treatment
shift
migrat
posit
increas
bind
figur
lane
contrast
chabc
littl
effect
commerci
bovin
aggrecan
reveal
minor
compon
comigr
antiaggrecan
bind
bind
elimin
treatment
keratanas
either
alon
treatment
chabc
consist
find
pretreat
tissu
section
human
trachea
chabc
result
equal
cartilag
increas
submucos
gland
bind
figur
chabc
treatment
subsequ
treatment
keratanas
complet
elimin
bind
addit
valid
ident
ligand
extract
human
trachea
obtain
treat
purifi
size
class
proteas
also
known
cleav
select
site
aggrecan
figur
size
class
ligand
treatment
result
shift
molecular
size
accompani
reduct
elimin
bind
case
remain
bind
comigr
electrophoresi
antibodi
reactiv
region
aggrecan
suggest
proteolyt
fragment
ntermin
ksrich
region
aggrecan
human
tracheal
ligand
increas
apoptosi
primari
human
eosinophil
abund
human
tracheal
ligand
good
chromatograph
resolut
figur
purifi
singl
donor
combin
structur
function
studi
pool
fraction
three
consecut
sephacryl
sizeexclus
run
load
repeatedli
onto
affin
column
column
wash
time
bound
ligand
saltelut
figur
reload
flowthrough
four
time
sampl
affin
purifi
elut
fraction
affin
chromatographi
run
pool
portion
combin
fraction
subject
mass
spectrometr
proteom
figur
anoth
portion
use
test
biolog
activ
match
experiment
control
sampl
prepar
treat
equal
portion
purifi
ice
without
addit
mm
sodium
period
min
sampl
excess
glycerol
mm
follow
mm
sodium
borohydrid
ice
min
cold
mild
period
treatment
result
select
oxid
sialic
acid
glycerol
side
chain
complet
abrog
bind
figur
freshli
isol
human
peripher
blood
eosinophil
cultur
overnight
interleukin
activ
addit
h
equal
portion
intact
oxid
oxid
ligand
effect
wherea
intact
ligand
significantli
increas
human
eosinophil
apoptosi
figur
although
siglec
express
eosinophil
abil
ligand
purifi
affin
chromatographi
induc
eosinophil
apoptosi
suggest
respons
via
bind
member
siglec
famili
sialic
acidbind
protein
human
express
subset
immun
cell
believ
immun
regulatori
either
inhibit
activ
depend
particular
siglec
cellular
context
macauley
et
al
varki
et
al
mani
siglec
carri
itim
andor
itimlik
domain
intracellular
cterminu
implic
role
inhibitori
immun
regul
implic
support
experi
use
human
immun
cell
anim
model
nutku
et
al
von
gunten
et
al
yokoi
et
al
cho
et
al
mcmillan
et
al
indic
engag
certain
siglec
result
immun
cell
apoptosi
event
associ
immun
inhibit
eg
block
immun
mediat
releas
presum
immun
cell
carri
siglec
surfac
come
contact
optim
sialoglycan
ligand
immun
target
tissu
result
transmembran
signal
initi
immun
inhibit
schleimer
et
al
scenario
particularli
well
establish
case
surfac
eosinophil
mast
cell
experiment
treatment
antibodi
synthet
multival
sialoglycan
polym
result
reactiv
oxygen
speci
fig
treatment
human
airway
ligand
shift
electrophoret
migrat
ligand
extract
human
trachea
purifi
sequenti
size
exclus
follow
affin
chromatographi
subject
chabc
aggrecanas
enzym
sampl
resolv
acrylamid
agaros
composit
gel
blot
pvdf
membran
probe
precomplex
antiaggrecan
antibodi
indic
lane
enzym
treatment
h
incub
without
enzym
aggrecanas
muml
aggrecanas
muml
plu
chabc
uml
chabc
uml
resolv
acrylamid
agaros
composit
gel
migrat
posit
himark
molecular
weight
marker
shown
resolv
acrylamid
agaros
composit
gel
migrat
posit
seeblu
molecular
weight
marker
shown
fig
purifi
human
tracheal
ligand
induc
human
eosinophil
apoptosi
ligand
extract
human
trachea
purifi
sizeexclus
chromatographi
follow
affin
chromatographi
portion
purifi
treat
cold
period
select
oxid
glycerol
sidearm
sialic
acid
follow
sodium
borohydrid
reduct
neg
control
equal
portion
incub
without
period
treat
sodium
borohydrid
intact
ligand
oxid
intact
dialyz
rpmi
medium
ad
equal
concentr
freshli
isol
primari
human
eosinophil
h
cultur
eosinophil
apoptosi
quantifi
flow
cytometri
oxid
intact
k
electrophoret
resolv
composit
agaroseacrylamid
gel
blot
pvdf
membran
replic
blot
probe
reveal
ligand
antiaggrecan
antibodi
lane
untreat
period
oxid
reduc
reduc
intact
ligand
b
isol
overnight
interleukin
prime
human
eosinophil
incub
equal
portion
oxid
intact
apoptosi
assess
h
later
result
express
rel
untreat
eosinophil
averag
apoptosi
sem
data
display
mean
sem
six
replic
perform
three
separ
primari
human
eosinophil
prepar
depend
apoptosi
activ
eosinophil
andor
inhibit
immun
mediat
releas
activ
mast
cell
nutkubilir
et
al
yokoi
et
al
hudson
et
al
carrol
et
al
inhibit
believ
compon
natur
resolut
immun
respons
find
potenti
basi
antiinflammatori
therapi
bochner
kiwamoto
et
al
ident
endogen
sialoglycan
ligand
engag
vivo
yet
establish
address
use
anim
model
sinc
found
hominida
human
chimpanze
orangutan
monkey
dog
rodent
angata
et
al
hudson
et
al
although
mice
function
paralog
siglecf
eosinophil
ligand
absent
mous
airway
yu
et
al
siglecfdepend
apoptosi
mous
eosinophil
quit
modest
comparison
human
mao
et
al
observ
make
imper
use
human
airway
tissu
sourc
isol
identifi
human
airway
ligand
data
present
consid
prior
publish
data
indic
sialyl
ks
termin
sequenc
glcnac
perhap
conjunct
determin
endogen
ligand
human
airway
prior
glycan
array
bind
bochner
et
al
schnaar
custom
sialoglycan
array
data
report
figur
indic
among
specif
lectin
known
bind
sialic
acid
bound
galactos
array
consortium
function
glycom
cfg
http
wwwfunctionalglycomicsorg
array
test
figur
molecular
basi
specif
determin
nmr
structur
analysi
propster
et
al
sialic
acidbind
site
sialic
acid
carboxyl
make
salt
bridg
flank
secondari
bind
site
make
salt
bridg
andor
hydrogen
bond
galactos
togeth
clamp
termin
structur
gal
place
propos
sinc
glcnac
residu
ks
disaccharid
uniformli
lauder
et
al
brown
et
al
seko
et
al
sialyl
disulf
trisaccharid
glcnac
ks
key
bind
compon
comparison
bind
form
sialyl
lewi
x
glcnac
glcnac
array
bind
campanerorhod
et
al
nmr
titrat
propster
et
al
reveal
modest
effect
addit
sulfat
glcnac
residu
isol
intact
ks
chain
human
airway
comparison
nonbind
speci
may
reveal
subtleti
complex
endogen
determin
addit
sialyl
sulfat
ks
chain
also
fucosyl
role
fucos
bind
endogen
ligand
isol
human
airway
determin
howev
glycan
array
bind
consist
shown
fucosyl
nonfucosyl
version
glycan
termin
sialyl
galactos
bind
current
array
figur
bound
somewhat
better
fucosyl
form
wherea
cfg
array
revers
true
yu
et
al
isol
endogen
ks
chain
requir
resolv
potenti
presenc
role
fucos
bind
previous
report
sialidasesensit
submucos
gland
cartilagebind
determin
human
airway
jia
et
al
yu
et
al
disappear
keratanas
treatment
figur
indic
carri
ks
chain
nonetheless
discoveri
aggrecan
ks
cs
proteoglycan
major
detect
protein
carrier
siglec
ligand
remain
surpris
even
though
aggrecan
genet
polymorph
associ
asthma
vaillancourt
et
al
although
aggrecan
abund
cartilag
presenc
submucos
gland
well
establish
exposur
eosinophil
mast
cell
endogen
ligand
like
occur
airway
surfac
rather
within
cartilag
layer
hypothesi
unusu
isoform
human
aggrecan
bind
support
near
absenc
bind
purifi
bovin
articular
cartilag
aggrecan
figur
furthermor
enrich
ligand
affin
chromatographi
aggrecan
similarli
enrich
detect
antiaggrecan
bind
data
shown
conclud
subpopul
aggrecan
glycoform
capabl
bind
wherea
glycoform
human
airway
bovin
articular
cartilag
fail
bind
accord
terminolog
propos
distinguish
lectinbind
glycoform
common
protein
taylor
et
al
aggrecan
glycoform
bind
may
design
aggrecan
distinguish
aggrecan
glycoform
fail
bind
relationship
three
molecular
weight
aggrecan
isoform
yet
determin
although
smaller
proteoglycan
may
includ
proteolyt
fragment
highconfid
ctermin
peptid
identifi
figur
tabl
suggest
may
case
interestingli
wherea
migrat
composit
gel
electrophoresi
increas
chabc
treatment
without
lose
bind
figur
migrat
unchang
data
shown
possibl
migrat
composit
gel
electrophoresi
reflect
differenti
splice
differenti
glycosyl
proteolyt
cleav
form
propos
brain
aggrecan
isoform
virgintino
et
al
major
remain
question
whether
aggrecan
form
express
submucos
gland
airway
whether
sialyl
ks
proteoglycan
produc
submucos
gland
either
case
conclud
unusu
subclass
sialyl
ks
proteoglycan
major
compon
human
airway
may
function
control
eosinophil
mast
cellmedi
inflamm
human
fc
produc
describ
kikli
et
al
keratanas
pseudomona
sp
chondroitinas
abc
proteu
vulgari
amsbio
cambridg
recombin
truncat
form
keratanas
ii
bacillu
circulan
produc
escherichia
coli
use
express
plasmid
kindli
provid
dr
andrew
muscrofttaylor
glycosyn
new
zealand
express
purifi
essenti
describ
steward
et
al
recombin
vibrio
cholera
sialidas
kindli
provid
dr
garri
taylor
univers
st
andrew
purifi
produc
e
coli
express
plasmid
describ
moustafa
et
al
mountney
et
al
recombin
human
aggrecanas
r
system
minneapoli
mn
pngase
f
new
england
biolab
ipswich
lacnac
lacnac
lacnac
lacnac
synthes
describ
chernyak
et
al
cheng
et
al
commerci
aggrecan
milliporesigma
burlington
extract
bovin
articular
cartilag
chromatograph
purifi
dialyz
water
sterilefilt
lyophil
construct
pentaval
figur
base
publish
concept
voulgaraki
et
al
plasmid
contain
extracellular
domain
follow
biotin
acceptor
peptid
bap
factor
xa
cleavag
site
iglik
domain
rat
comp
pentamer
domain
ctermin
tag
behind
promot
creat
follow
extracellular
domain
amplifi
polymeras
chain
reaction
pcr
use
primer
complementari
synthet
dna
oligonucleotid
anneal
doublestrand
fragment
contain
mlui
nhei
restrict
site
flank
ecori
kpni
site
insert
pefgfp
addgen
plasmid
gift
dr
conni
cepko
matsuda
cepko
pcr
product
clone
modifi
pefgfp
mlui
nhei
site
creat
complementari
synthet
dna
oligonucleotid
encod
bap
factor
xa
cleavag
site
tccgccggaggctctggaggcctgaacgatattttcgaag
ctcagaaaatcgaatggcacgaaatcgagggaaggtcgg
attttctgagcttcgaaaatatcgttcaggcctccagagcc
anneal
clone
nhei
kpni
site
creat
final
kpninoti
fragment
vector
basigincd
addgen
plasmid
gift
gavin
wright
crosnier
et
al
clone
xgfp
creat
express
vector
shown
figur
cell
maintain
dulbecco
modifi
eagl
medium
fetal
bovin
serum
confluenc
cell
transfect
use
lipofectamin
thermo
fisher
scientif
waltham
cultur
supernat
collect
day
load
onto
nickel
sepharos
bead
ligand
affin
chromatographi
see
purifi
via
ctermin
tag
size
bind
studi
figur
follow
cultur
supernat
load
onto
ninta
superflow
cartridg
qiagen
germantown
md
wash
nacl
mm
imidazol
mm
mm
sodium
phosphat
ph
column
wash
buffer
contain
nacl
product
elut
buffer
contain
mm
imidazol
purifi
protein
dialyz
dulbecco
phosphatebuff
salin
pb
character
sizeexclus
chromatographi
sdspage
gel
electrophoresi
immunoblot
glycan
bind
custom
sialoglycan
array
figur
sizeexclus
chromatographi
perform
use
superdex
gl
column
ge
healthcar
bioscienc
pittsburgh
pa
chromatographi
system
ge
healthcar
compar
elut
pattern
commerci
mixtur
protein
milliporesigma
sdspage
perform
use
nupag
bistri
precast
polyacrylamid
gel
seeblu
molecular
weight
marker
thermo
fisher
immunoblot
perform
transfer
pvdf
membran
use
alkalin
phosphateconjug
monoclon
antibodi
thermo
fisher
detect
use
vector
red
vector
laboratori
sialoglycanbind
specif
test
incub
slideprint
array
contain
sialoglycan
neutral
glycan
li
et
al
supplementari
data
tabl
bind
detect
wash
incub
alexa
fluor
antihi
antibodi
qiagen
ligand
resolv
sd
gel
electrophoresi
composit
agaroseacrylamid
gel
agaros
acrylamid
indic
h
v
condit
suitabl
resolut
larg
glycoprotein
molecul
jia
et
al
yu
et
al
sampl
guhcl
buffer
see
dialyz
urea
buffer
urea
mm
sodium
phosphat
ph
prior
electrophoresi
resolv
protein
electroblot
onto
polyvinyliden
fluorid
pvdf
membran
iblot
thermo
fisher
membran
block
nonfat
milk
dissolv
pb
supplement
pbst
min
horseradish
peroxidas
hrp
conjug
antihuman
fc
milliporesigma
incub
total
pbst
min
ice
dilut
ml
pbst
blot
overlaid
precomplex
mixtur
h
altern
blot
incub
one
two
antiaggrecan
antibodi
pbst
mab
domain
biorad
hercul
ca
ii
polyclon
domain
thermo
fisher
blot
wash
incub
appropri
hrpconjug
secondari
antibodi
pbst
h
ambient
temperatur
hrp
antibodi
bind
detect
use
enhanc
chemiluminesc
ge
healthcar
molecular
weight
marker
includ
indic
seeblu
himark
thermo
fisher
trachea
obtain
four
human
organ
donor
donor
year
old
time
death
includ
three
women
one
man
two
smoker
two
nonsmok
one
report
allerg
rhiniti
report
airway
diseas
caus
death
includ
anoxia
secondari
cardiac
arrest
two
donor
head
trauma
stroke
organ
flush
store
htk
solut
uw
solut
kept
ice
h
prior
dissect
latchana
et
al
trachea
dissect
free
surround
tissu
transfer
icecold
contain
antibiot
uml
penicillin
streptomycin
process
histolog
andor
protein
extract
trachea
cut
small
piec
frozen
liquid
nitrogen
pulver
use
liquid
nitrogenchil
mortar
pestl
base
weight
pulver
tissu
extract
buffer
ad
guhcl
omnipur
milliporesigma
mm
edta
mm
sodium
phosphat
ph
plu
proteas
inhibitor
cocktail
milliporesigma
ratio
mlg
pulver
tissu
suspens
incub
h
endoverend
mix
centrifug
g
min
pellet
discard
supernat
use
immedi
store
sizeexclus
chromatographi
aliquot
tissu
extract
dialyz
run
buffer
guhcl
mm
sodium
phosphat
ph
use
floatalyz
kda
mwco
spectrum
lab
rancho
dominguez
ca
dialyz
sampl
ml
load
onto
hiprep
sephacryl
hr
column
ge
healthcar
chromatographi
system
ge
healthcar
flow
rate
mlmin
inject
ml
total
column
volum
eluat
discard
fraction
collect
full
column
volum
ml
elut
aliquot
fraction
dot
onto
pvdf
membran
use
biodot
microfiltr
apparatu
biorad
probe
bind
posit
fraction
individu
dialyz
urea
buffer
resolut
composit
agaroseacrylamid
gel
electrophoresi
blot
describ
fraction
pool
base
electrophoret
migrat
purif
affin
chromatographi
medium
cell
express
filter
stericup
milliporesigma
cool
pack
volum
nickel
sepharos
resin
ge
healthcar
prewash
ml
bind
buffer
mm
nacl
mm
sodium
phosphat
mm
imidazol
ph
medium
contain
ml
cycl
prewash
nickel
bead
h
use
peristalt
pump
column
wash
ml
highsalt
elut
buffer
urea
nacl
mm
sodium
phosphat
mm
imidazol
ph
equilibr
ml
urea
buffer
combin
fraction
sizeexclus
chromatographi
dialyz
urea
buffer
preclear
cycl
three
time
ml
nickel
sepharos
resin
without
sigleccomp
preequilibr
ml
urea
buffer
preclear
sampl
load
onto
column
cycl
three
time
column
wash
ml
low
salt
wash
urea
mm
nacl
mm
sodium
phosphat
mm
imidazol
ph
collect
fraction
ligand
elut
use
highsalt
elut
buffer
collect
one
fraction
subsequ
fraction
salt
elut
releas
ligand
without
elut
equal
volum
fraction
load
composit
gel
analyz
describ
indic
purifi
ligand
treat
enzym
prior
resolv
blot
ligand
dialyz
pb
prior
incub
sialidas
chabc
keratanas
keratanas
ii
aggrecanas
indic
figur
legend
control
ligand
treat
similarli
without
enzym
test
whether
ligand
bound
immobil
via
sialoglycanbind
site
elut
synthet
glycan
test
figur
purifi
immobil
magnet
nickel
sepharos
bead
ge
healthcar
sizesepar
urea
buffer
incub
bead
overnight
mix
endoverend
bead
wash
three
time
mm
nacl
mm
imidazol
mm
sodium
phosphat
ph
bead
bound
suspend
urea
buffer
distribut
equal
microcentrifug
tube
urea
buffer
remov
replac
urea
buffer
alon
buffer
contain
mm
synthet
lacnac
lacnac
lacnac
lacnac
h
supernat
collect
remain
ligand
elut
mm
imidazol
urea
buffer
equival
aliquot
glycan
imidazol
elut
resolv
composit
gel
electrophoresi
blot
probe
bind
affinitypurifi
saltelut
desalt
centrifug
ultrafiltr
amicon
ultra
ml
k
milliporesigma
follow
reduct
mm
dithiothreitol
h
carbamidomethyl
mm
iodoacetamid
dark
min
protein
digest
sequencegrad
recombin
lysc
trypsin
promega
madison
wi
h
result
peptid
purifi
pierc
tip
thermo
fisher
peptid
elut
acetonitril
tfa
purifi
saltelut
resolv
prepar
sdspage
nupag
precast
gel
himarkprestain
protein
standard
thermo
fisher
base
migrat
standard
section
gel
contain
resolv
excis
cut
small
piec
wash
mm
ammonium
bicarbon
acetonitril
reduc
alkyl
use
mm
dithiothreitol
mm
iodoacetamid
piec
rewash
bicarbon
acetonitril
rehydr
mm
ammonium
bicarbon
contain
lysc
trypsin
incub
h
result
peptid
extract
sequenti
incub
acetonitril
aqueou
formic
acid
wash
combin
dri
purifi
use
pierc
tip
purifi
peptid
reconstitut
mobil
phase
formic
acid
water
mobil
phase
b
acetonitril
formic
acid
water
pass
nanosep
mf
centrifug
devic
pall
port
washington
ny
transfer
autosampl
vial
sampl
analyz
use
orbitrap
fusion
lumo
tribrid
mass
spectromet
thermo
fisher
equip
rslcnano
liquid
chromatograph
use
analyt
column
acclaim
pepmap
mm
thermo
fisher
inject
peptid
elut
use
multistep
gradient
mobil
phase
b
flow
rate
min
peptid
fragment
use
higher
energi
collision
dissoci
electron
transfer
dissoci
collisioninduc
dissoci
electrospray
ioniz
voltag
kv
capillari
temperatur
full
scan
mass
spectra
acquir
posit
ion
mode
rang
mz
use
orbitrap
mass
analyz
profil
format
mass
resolut
set
scan
collect
quadrupol
ion
trap
intens
ion
topspe
mode
within
cycl
centroid
format
use
fusion
instrument
softwar
version
thermo
fisher
follow
paramet
isol
width
mz
unit
normal
collis
energi
charg
state
activ
q
activ
time
ms
realtim
dynam
exclus
enabl
preclud
reselect
previous
analyz
precursor
ion
dulbecco
phosphatebuff
salin
pcr
polymeras
chain
reaction
pvdf
polyvinyliden
fluorid
sdspage
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
